Atlanta, GA, United States of America

Chamberlain Obialo

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Morehouse School of Medicine. Active years: 2016-2024.

USPTO Granted Patents = 7 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Peachtree City, GA (US) (2017 - 2020)
  • Atlanta, GA (US) (2016 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Chamberlain Obialo: Innovator in Kidney Disease Research

Introduction

Chamberlain Obialo is an accomplished inventor based in Atlanta, GA, known for his significant contributions to medical research and innovation. With a total of seven patents to his name, Obialo has made remarkable strides in the treatment and detection of kidney diseases related to endothelin-1.

Latest Patents

Obialo's latest patents focus on groundbreaking methods and compositions for the treatment of HIV-associated nephropathy (HIVAN) and focal segmental glomerulosclerosis (FSGS). His innovative work involves using endothelin-1 (ET-1) antagonists to effectively treat these kidney conditions. Additionally, he has developed a kit designed to detect the presence of ET-1 or associated biomarkers in biological samples, thus enhancing diagnostic capabilities for these serious diseases.

Career Highlights

Chamberlain Obialo currently works at Morehouse School of Medicine, a leading institution dedicated to medical education and research. His career is characterized by his dedication to improving health outcomes for patients suffering from severe kidney diseases. With a commitment to advancing medical technology, Obialo's work has the potential to transform treatment approaches in the field.

Collaborations

Throughout his career, Obialo has collaborated with esteemed colleagues such as Gale W. Newman and Mike Powell. These partnerships underscore the collaborative spirit of innovation within the medical research community. Together, they strive to push the boundaries of existing knowledge and develop new solutions for complex health issues.

Conclusion

Chamberlain Obialo stands out as a key figure in the realm of kidney disease research, with a focus on innovative treatments and diagnostic methods. His contributions not only highlight the importance of medical innovation but also reflect a broader commitment to enhancing patient care. As he continues to work at Morehouse School of Medicine and pursue further inventions, the potential impact of his research is poised to benefit many in need of advanced medical interventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…